Jin Zhang

Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial

Julie R. Brahmer, Delvys Rodríguez‐Abreu, Andrew Robinson et al. · The Lancet Oncology · 2017 · 349 citations

Medicine, Oncology, Pharmacotherapy +12

The m6A-suppressed P2RX6 activation promotes renal cancer cells migration and invasion through ATP-induced Ca2+ influx modulating ERK1/2 phosphorylation and MMP9 signaling pathway

Dongkui Gong, Jin Zhang, Yonghui Chen et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 114 citations · Full text

Medicine, Molecular Biology, Oncology +17

Fluorofenidone attenuates pulmonary inflammation and fibrosis <i>via</i> inhibiting the activation of <scp>NALP</scp>3 inflammasome and <scp>IL</scp>‐1β/<scp>IL</scp>‐1R1/MyD88/<scp>NF</scp>‐κB pathway

Cheng Song, Lujuan He, Jin Zhang et al. · Journal of Cellular and Molecular Medicine · 2016 · 109 citations · Full text

Veterinary Medicine, Immunology, Pharmacology +17

SUV39H1 deficiency suppresses clear cell renal cell carcinoma growth by inducing ferroptosis

Jianfeng Wang, Xiaomao Yin, Wei He et al. · Acta Pharmaceutica Sinica B · 2020 · 107 citations · Full text

Medicine, Molecular Biology, Oncology +17

Predictive value of single-nucleotide polymorphism signature for recurrence in localised renal cell carcinoma: a retrospective analysis and multicentre validation study

Jinhuan Wei, Zi-Hao Feng, Yun Cao et al. · The Lancet Oncology · 2019 · 95 citations

Medicine, Molecular Genetics, Oncology +16